These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3786826)

  • 1. Committee on Science and Technology, U.S. House of Representatives, Washington, D.C. 20515. Opening statement: Subcommittee on Investigations and Oversight, July 23, 1986.
    Volkmer HL
    Recomb DNA Tech Bull; 1986 Sep; 9(3):134-6. PubMed ID: 3786826
    [No Abstract]   [Full Text] [Related]  

  • 2. United States Department of Agriculture statement before the Subcommittee on Investigations and Oversight, Subcommittee on Natural Resources, Agriculture Research and Environment, Subcommittee on Science, Research and Technology, U.S. House of Representatives Committee on Science and Technology, July 23, 1986.
    Darling K
    Recomb DNA Tech Bull; 1986 Sep; 9(3):195-202. PubMed ID: 3786831
    [No Abstract]   [Full Text] [Related]  

  • 3. Testimony of Assistant Administrator for Pesticides and Toxic Substances, U.S. Environmental Protection Agency before the Subcommittee on Investigations and Oversight, the Subcommittee on Natural Resources, Agriculture Research and Environment, and the Subcommittee on Science, Research and Technology of the U.S. House of Representatives Committee on Science and Technology, July 23, 1986.
    Moore JA
    Recomb DNA Tech Bull; 1986 Sep; 9(3):178-85. PubMed ID: 3786829
    [No Abstract]   [Full Text] [Related]  

  • 4. United States Department of Agriculture statement of Assistant Secretary for Science and Education before the House Committee on Science and Technology, July 23, 1986, Subcommittee on Investigations and Oversight and Subcommittee on Science, Research and Technology and Subcommittee on Natural Resources, Agricultural Research and Environment.
    Bentley OG
    Recomb DNA Tech Bull; 1986 Sep; 9(3):186-94. PubMed ID: 3786830
    [No Abstract]   [Full Text] [Related]  

  • 5. Testimony of the American Society for Microbiology before the House Subcommittee on Investigations and Oversight, House Subcommittee on Natural Resources, Agriculture Research and Environment, and the House Subcommittee on Science, Research and Technology of the House Committee on Science and Technology. Hearing on "The coordinated framework for the regulation of biotechnology", July 23, 1986.
    Riley M
    Recomb DNA Tech Bull; 1986 Sep; 9(3):151-61. PubMed ID: 3466239
    [No Abstract]   [Full Text] [Related]  

  • 6. Testimony of the Ecological Society of America on the coordinated framework for the regulation of biotechnology. Presented to U.S. House of Representatives Committee on Science and Technology, Subcommittees on: Investigations and Oversight, Natural Resources, Agriculture Research and Environment and Science, Research and Technology, July 23, 1986.
    Norse EA
    Recomb DNA Tech Bull; 1986 Sep; 9(3):171-7. PubMed ID: 3466241
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement of Assistent Director, Biological, Behavioral and Social Sciences, National Science Foundation before the Subcommittee on Science, Research, and Technology, U.S. House of Representatives, July 23, 1986.
    Kingsbury DT
    Recomb DNA Tech Bull; 1986 Sep; 9(3):139-50. PubMed ID: 3786828
    [No Abstract]   [Full Text] [Related]  

  • 8. Testimony of the Industrial Biotechnology Association before the Subcommittees on Natural Resources, Agriculture Research and Environment; Science, Research and Technology; and Investigations and Oversight of the Committee on Science and Technology, House of Representatives, July 23, 1986.
    Godown R
    Recomb DNA Tech Bull; 1986 Sep; 9(3):203-10. PubMed ID: 3786832
    [No Abstract]   [Full Text] [Related]  

  • 9. Testimony before the Subcommittee on Natural Resources, Agriculture Research and Environment, and the Subcommittee on Science, Research and Technology of the Committee on Science and Technology, June 23, 1986.
    Mellon MG
    Recomb DNA Tech Bull; 1986 Sep; 9(3):162-70. PubMed ID: 3466240
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethical and social issues in the application of genetic engineering to human beings. Statement to Subcommittee on Investigations and Oversight, Committee on Science and Technology, United States House of Representatives.
    Capron AM
    Recomb DNA Tech Bull; 1983 Mar; 6(1):3-10. PubMed ID: 6573729
    [No Abstract]   [Full Text] [Related]  

  • 11. Opening statement: Joint hearing on federal coordination policy for biotechnology, July 23, 1986.
    Walgren D
    Recomb DNA Tech Bull; 1986 Sep; 9(3):137-8. PubMed ID: 3786827
    [No Abstract]   [Full Text] [Related]  

  • 12. Testimony of George E. Hardy, Jr., M. D., M. P. H. Health Officer, Jefferson County Department of Health. Before the House Subcommittee on Public Health and Environment of the House Committee on Interstate and Foreign Commerce, U. S. House of Representatives, Washington, D. C. on Thursday, April 27, 1972.
    Hardy GE
    J Med Assoc State Ala; 1972 Jul; 42(1):12 passim. PubMed ID: 5044794
    [No Abstract]   [Full Text] [Related]  

  • 13. Statement of the American Medical Association to the Select Education Subcommittee, Committee on Education and Labor, U. S. House of Representatives. Re: H. R. 6492--Handicapped Infants Protection Act, September 1982.
    Conn Med; 1983 Jan; 47(1):29-30. PubMed ID: 6825425
    [No Abstract]   [Full Text] [Related]  

  • 14. Statement of the American Medical Association before the Subcommittee on Rural Development. Committee on Agriculture U.S. House of Representatives.
    Reiheld RE
    Ohio State Med J; 1975 Jan; 71(1):44-6. PubMed ID: 1109472
    [No Abstract]   [Full Text] [Related]  

  • 15. Legislative update.
    Common Factor; 1995 Apr; (no 10):36. PubMed ID: 11362354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statement by the American Society for Medcial Technology in consideration of the proposed recombinant DNA legislation: submitted to the Senate Subcommittee on Health of the Human Resource Committee and to the House Subcommittee on Health of the Interstate Foreign Commerce Committee. September 7, 1977.
    Am J Med Technol; 1978 Jan; 44(1):66. PubMed ID: 623146
    [No Abstract]   [Full Text] [Related]  

  • 17. Statement of the American Medical Association before the Subcommittee on Health Committee on Ways and Means United States House of Representatives. Health care competition legislation.
    Rainey FC
    Conn Med; 1982 May; 46(5):267-70. PubMed ID: 7047071
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotechnology report clears House Science Committee hurdles.
    Crawford M
    Science; 1986 Nov; 234(4777):668. PubMed ID: 3775359
    [No Abstract]   [Full Text] [Related]  

  • 19. OxyContin abuse and diversion and efforts to address the problem: highlights of a government report.
    Government Accounting Office
    J Pain Palliat Care Pharmacother; 2004; 18(3):109-13. PubMed ID: 15364638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ricky Ray scheduled for subcommittee mark-up and vote.
    Kuhn D; Rice T
    Common Factor; 1997 Nov; (No 11):1, 17. PubMed ID: 11364842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.